Ren Benjamin Quotes (4 Quotes)

We think it's going to be good news for all the stem cell players. This sort of news and this sort of media attention really brings all the attention into the biotech space and the stem cell stocks tend to do really well.

Investors should be aware that biotech companies, especially in the stem-cell space, tend to move with the news flow, ... If there's bad news, like if Bush vetoes this bill as he promised he will, the prices could go back to more reasonable valuations.

It gives them more leverage. If your cost of goods is lower, you have more leverage to negotiate prices that might be able to beat out competing technologies.

You might see -- for lack of a better word -- money being thrown around for different therapies. There could be a number of winners.